Australia - angielski - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 100 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections; glycine; human immunoglobulin a - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections; human immunoglobulin a; glycine - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

marketing brokers australia pty ltd - bromhexine hydrochloride, quantity: 800 microgram/ml; guaifenesin, quantity: 20 mg/ml - oral liquid - excipient ingredients: povidone; sorbitol solution (70 per cent) (non-crystallising); citric acid; saccharin sodium; sodium benzoate; allura red ac; purified water; maltol; flavour - symptomatic relief from congested chests and coughs due to the common cold. dimetapp chesty cough elixir contains the expectorant guaiphenesin, which increases the flow of natural secretions along the respiratory tract. it also contains bromhexine hydrochloride to liquefy and breakdown secretions. this combination helps break up a cough - helps loosen congestion so you can cough it up and get it off your chest.

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - bromhexine hydrochloride - unknown - bromhexine hydrochloride guanidine active 0.0 - active constituent

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bromhexine hydrochloride - unknown - bromhexine hydrochloride guanidine active 0.0 - active constituent

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - bromhexine hydrochloride - unknown - bromhexine hydrochloride guanidine active 0.0 - active constituent

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - bromhexine hydrochloride; trimethoprim; sulfadimidine - oral powder, pre-mix - bromhexine hydrochloride guanidine active 8.6 mg/g; trimethoprim pyrimidine active 86.0 mg/g; sulfadimidine sulfanyl active 430.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - infections of the respiratory tract | acute respiratory infections | bronchiseptica | bronchitis | pharyngitis | pneumonia | tonsillitis

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

inova pharmaceuticals (singapore) pte ltd (incorporated in singapore) malaysia branch - bromhexine hcl; pholcodine -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - bromhexine hydrochloride -